Innophos Holdings Inc (IPHS) Jumps 5.8% on January 21

Equities Staff  |

Innophos Holdings Inc (IPHS) was among the biggest gainers on the Russell 2000 for Thursday January 21 as the stock popped 5.8% to $24.79, representing a gain of $1.36 per share. Some 222,754 shares traded hands on 2,142 trades, compared with an average daily volume of 192,621 shares out of a total float of 19.24 million. The stock opened at $23.42 and traded with an intraday range of $25.37 to $23.23.

After today's gains, Innophos Holdings Inc reached a market cap of $476.92 million. Innophos Holdings Inc has had a trading range between $63.29 and $22.06 over the last year, and it had a 50-day SMA of $29.30 and a 200-day SMA of $43.61.

The stock has a P/E Ratio of 11.7.

Innophos Holdings Inc is producer of specialty grade phosphate products for the Food, Pharmaceutical and Industrial market segments. Its products act as flavor enhancers in beverages, leavening agents in baked goods and cleaning agents in toothpaste.

Innophos Holdings Inc is based out of Cranbury, NJ and has some 1,445 employees. Its CEO is Kim Ann Mink.

For a complete fundamental analysis analysis of Innophos Holdings Inc, check out’s Stock Valuation Analysis report for IPHS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd through its subsidiary operates as a cannabinoid-based research and development company in Canada.